Scarica l'app Stockscreener
4.83
3.35%
-0.1673
Precedente Chiudi:
$4.9973
Aprire:
$4.94
Volume 24 ore:
9,999
Relative Volume:
0.34
Capitalizzazione di mercato:
$17.89M
Reddito:
$11.68M
Utile/perdita netta:
$-8.85M
Rapporto P/E:
-2.0041
EPS:
-2.41
Flusso di cassa netto:
$-14.61M
1 W Prestazione:
-9.04%
1M Prestazione:
-23.45%
6M Prestazione:
-35.51%
1 anno Prestazione:
+101.25%
Intervallo 1D:
$4.80
$4.9986
Intervallo di 1 settimana:
$4.80
$5.44
Portata 52W:
$1.78
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Nome
Pulmatrix Inc
Settore
Industria
Telefono
(888) 355-4440
Indirizzo
945 CONCORD STREET, FRAMINGHAM, MA
Confronta PULM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.8992 | 18.26M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.39 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.87 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.40 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.90 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
303.40 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-02-09 | Iniziato | H.C. Wainwright | Buy |
Pulmatrix Inc Borsa (PULM) Ultime notizie
Has Pulmatrix Inc. found a price floorStop Loss & Free AI Powered Buy and Sell Recommendations - Newser
What analysts say about Pulmatrix Inc. stock outlookJuly 2025 Levels & Community Trade Idea Sharing Platform - Newser
What high frequency data says about Pulmatrix Inc. [2025 Market Trends]Free Verified Technical Trade Signals - Newser
Applying sector rotation models to Pulmatrix Inc.Risk Aware Trading Ideas with Alert Levels - Newser
Pulmatrix Inc. stock retracement – recovery analysisSwing Trade Entry and Exit Point Analysis - Newser
How high can Pulmatrix Inc. stock price go in 2025Insider Buying & Daily Entry Point Trade Alerts - Newser
Pulmatrix Inc. Ranks High in Smart Money TrackerWatchlist for Smart Swing Trading Updated - 선데이타임즈
Tools to assess Pulmatrix Inc.’s risk profileAlgorithmic Prediction of Market Breakouts - Newser
Measuring Pulmatrix Inc.’s beta against major indicesFree Reliable Investment Entry Point Signals - Newser
How Pulmatrix Inc. stock performs during market volatilityWatchlist Generator With Real-Time Entry - Newser
Using Ichimoku Cloud for Pulmatrix Inc. technicalsRisk Managed Watchlist with Breakout Picks - Newser
Tick level data insight on Pulmatrix Inc. volatilityFree Day Trading Signals With High Precision - Newser
Buy Signal for Pulmatrix Inc. Stock Key Technical Indicators to WatchFundamental + Technical Combined Watchlist - Newser
Building trade automation scripts for Pulmatrix Inc.Market Ready Picks with Technical Support - Newser
What Fibonacci levels say about Pulmatrix Inc. reboundDay Trading Plan with Entry Risk Management - Newser
Price action breakdown for Pulmatrix Inc.Scalable Strategy with Chart Confirmation - Newser
Pulmatrix Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingAI Screener Based Stock Summary Report - Newser
Detecting price anomalies in Pulmatrix Inc. with AIReal Time Trade Execution Alert Plan - Newser
Pulmatrix Inc. stock momentum explainedFree Trend Following Strategy With Stop Loss - Newser
When is the best time to exit Pulmatrix Inc.Real-Time Investment Picks with Accuracy - Newser
Is Pulmatrix Inc. showing signs of accumulationReal-Time Entry Forecast with Accuracy Metrics - Newser
Why Pulmatrix Inc. stock attracts strong analyst attentionReal Time Alert System for Market Moves - Newser
Short Interest in Pulmatrix, Inc. (NASDAQ:PULM) Expands By 51.2% - Defense World
Pulmatrix 2024 Q4 Earnings Narrowed Losses and Record Net Income - AInvest
Pulmatrix (PULM) Q2 Revenue Falls 100% - The Globe and Mail
Pulmatrix Reports Q2 2025 Financial Results, Plans Inhalation Asset Divestment Ahead of Cullgen Merger - AInvest
Pulmatrix to divest iSPERSE patent portfolio amid merger with Cullgen. - AInvest
Pulmatrix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Pulmatrix to potentially divest its patent portfolio for iSPERSE technology - TipRanks
Pulmatrix, Inc. SEC 10-Q Report - TradingView
Pulmatrix Announces Second Quarter 2025 Financial Results and Di - GuruFocus
Pulmatrix Q2 2025: Proposed merger to close in 2025, divesting iSPERSE technology. - AInvest
Pulmatrix Q2 revenue falls to zero, net loss widens - MarketScreener
Pulmatrix Announces Q2 2025 Results, Proposes Inhalation Assets Divestment. - AInvest
Pulmatrix to Divest 146-Patent Inhalation Technology Portfolio as Cullgen Merger Advances - Stock Titan
Forecasting Pulmatrix Inc. price range with options dataBuy and Exit Strategy Based on Momentum - Newser
Pulmatrix Inc Azioni (PULM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):